Alerts will be sent to your verified email
Verify Email
ONESOURCE
|
Onesource Specialty
|
Concord Biotech
|
Alembic Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
n/a | 20.02 % | 15.79 % |
|
5yr average Equity Multiplier
|
n/a | 1.26 | 1.48 |
|
5yr Average Asset Turnover Ratio
|
n/a | 0.52 | 0.83 |
|
5yr Avg Net Profit Margin
|
n/a | 30.81 % | 13.0 % |
|
Price to Book
|
44.46 | 10.83 | 3.55 |
|
P/E
|
0.0 | 52.8 | 28.71 |
|
5yr Avg Cash Conversion Cycle
|
n/a | 37.41 Days | 1.45 Days |
|
Inventory Days
|
n/a | 80.96 Days | 94.67 Days |
|
Days Receivable
|
n/a | 111.87 Days | 60.69 Days |
|
Days Payable
|
n/a | 173.13 Days | 176.63 Days |
|
5yr Average Interest Coverage Ratio
|
n/a | 137.55 | 36.16 |
|
5yr Avg ROCE
|
n/a | 25.59 % | 17.34 % |
|
5yr Avg Operating Profit Margin
|
n/a | 42.97 % | 19.56 % |
|
5 yr average Debt to Equity
|
n/a | 0.04 | 0.2 |
|
5yr CAGR Net Profit
|
n/a | 12.77 % | -5.77 % |
|
5yr Average Return on Assets
|
n/a | 15.93 % | 10.48 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
34.25 % | 44.08 % | 69.67 % |
|
Share Pledged by Promoters
|
20.06 % | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-3.52 % | 0.0 | 0.06 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
3.7 % | -0.42 % | 4.02 % |
|
Onesource Specialty
|
Concord Biotech
|
Alembic Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|